Treatment of acute myocardial infarction in the
sub-arctic region of Norway. Do we offer an equal
quality of care? by Norum, Jan et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=zich20
Download by: [178.74.33.250] Date: 26 October 2017, At: 23:23
International Journal of Circumpolar Health
ISSN: (Print) 2242-3982 (Online) Journal homepage: http://www.tandfonline.com/loi/zich20
Treatment of acute myocardial infarction in the
sub-arctic region of Norway. Do we offer an equal
quality of care?
J. Norum, A. Hovland, L. Balteskard, T. Trovik, B. Haug, F. H. Hansen, S.
Alterskjær, P. Madsen & F. Olsen
To cite this article: J. Norum, A. Hovland, L. Balteskard, T. Trovik, B. Haug, F. H. Hansen, S.
Alterskjær, P. Madsen & F. Olsen (2017) Treatment of acute myocardial infarction in the sub-
arctic region of Norway. Do we offer an equal quality of care?, International Journal of Circumpolar
Health, 76:1, 1391651, DOI: 10.1080/22423982.2017.1391651
To link to this article:  http://dx.doi.org/10.1080/22423982.2017.1391651
© 2017 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 26 Oct 2017.
Submit your article to this journal 
View related articles 
View Crossmark data
RESEARCH ARTICLE
Treatment of acute myocardial infarction in the sub-arctic region of Norway.
Do we offer an equal quality of care?
J. Noruma,b, A. Hovlandb,c, L. Balteskardd, T. Trovike, B. Haugf, F. H. Hanseng, S. Alterskjærf, P. Madsenh
and F. Olsend
aDepartment of Surgery, Finnmark Hospital, Hammerfest, Norway; bDepartment of Clinical Medicine, Faculty of Health Science, UiT - The
Arctic University of Norway, Tromsø, Norway; cDepartment of Cardiology, Nordland Hospital, Bodø, Norway; dCentre for Clinical
Documentation and Evaluation, Northern Norway Regional Health Authority trust, Tromsø, Norway; eDepartment of Cardiology, University
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ABSTRACT
Patients, relatives, healthcare workers and administrators are concerned about the quality of care
offered. We aimed to explore the treatment of acute myocatrdial infarction (AMI) in Northern
Norway, compare it with the national figures, and document whether there is an equal quality of
care or not. The retrospective study included data on patients' treatment for AMI. The following
sources were employed. The Norwegian Patient Registry, National Quality of Care Database,
Norwegian Myocardial Infarction Registry and data from the National Air Ambulance Services
of Norway. The period 2012-2014/15 was studied and the variables were: incidence of AMI,
gender and age adjusted rates of AMI and revascularization (PCI, CABG) based on patient's
place of living (according to hospital catchment area) and 30-day survival rate. The annual
incidence of AMI was 9% higher in the northern region. Significant incidence variations (2.7–5.9
AMI/1000 inhabitants) between the hospitals' catchment areas were revealed. The 30-day survival
rate varied between 85.1–92.1% between hospitals. The variation in revascularization/AMI rate
was 0.72–1.54. Air amublance services' availability varied through the day. In conclusion, sig-
nificant variations in the AMI rate and an unequal service within the region was revealed.
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Appropriate interventions may decrease the disability
and death rates due to acute myocardial infarction
(AMI) [1–4]. Several countries have added AMI to the
list of targets to be monitored and assessed at the
national level [1–4]. In this monitoring, hospital per-
formance has been compared based on quality of
care measures [5–9]. During the last decade, the inci-
dence of AMI and the case-fatal rate (CRF) has
decreased in several countries, including Norway
[10,11]. The improvements have been due to
advances in invasive treatments and medical man-
agement, such as pre-hospital thrombolytic therapy
and primary percutaneous coronary intervention
(PCI). However, regional variations in the AMI and
CFR and the causes thereof have been reported
[12–14]. Disproportionate differences in the medical
infrastructure, available in the main cities with PCI-
centres versus in other areas (without direct access to
a PCI centre), have been a focus of growing concern
in Norway and other countries [15].
Norway comprises the western portion of the
Scandinavian Peninsula, plus the island Jan Mayen and
the archipelago of Svalbard. The country has four
health regions. The northern region constitutes 45% of
Norway’s land mass (Svalbard inclusive), but has only
9.4% (0.5 million) of the country’s population (5.2 mil-
lion). Despite people being scattered within a substan-
tial area (173,966 km2), they have been promised, by
the Northern Norwegian Regional Health Authority
(NNRHA) trust, a healthcare of equal quality within the
whole region. To meet such expectations, the NNRHA
trust runs 11 medical hospitals and has 12 available air
ambulance resources (six fixed wing aircrafts, four
ambulance helicopters, two search and rescue helicop-
ters) scattered on the mainland [16,17]. The regional
PCI-centre is located at the University hospital of
North-Norway (UNN) in Tromsø. In this study, we
aimed to explore whether all these resources offer
patients suffering from AMI a similar quality of care
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This study was undertaken to document the quality of
care of AMI in Northern Norway. A retrospective design
was used and the treatment of AMI within the hospitals’
catchment areas was analysed. The hospitals were
Finnmark hospital Kirkenes, Finnmark hospital
Hammerfest, University hospital of North-Norway
Tromsø, University hospital of North-Norway Harstad,
University hospital of North-Norway Narvik, Nordland
hospital Vesterålen, Nordland hospital Lofoten,
Nordland hospital Bodø, Helgeland hospital Rana,
Helgeland hospital Sandnessjøen and Helgeland hospi-
tal Mosjøen. Locations and catchment areas are shown
in Figure 1. Svalbard was included in the UNN Tromsø´s
catchment area. The following four sources were
employed:
● The Norwegian Patient Registry (NPR). The period
2012–2014 was used when analysing data for the
whole country and 2013–2015 when performing
further sub-analysis of the northern region. This is
due to the fact that data on a national level was
not available for the period 2013–2015.
● The National Quality of Care Database (NQCD),
2012–2014.
● Norwegian Myocardial Infarction Registry (NMIR),
2015.
● The database at the National Air Ambulance
Services of Norway (NASN), 2012–2014.
In brief, all patients diagnosed and treated for AMI
(ICD-10, I21/I22) at any medical hospital in north
Norway during the period were eligible for the study
on incidence and treatment. The diagnosis was based
on the universal definition of myocardial infarction [18].
The NPR did not distinguish between ST-elevation myo-
cardial infarction (STEMI) and non-STEMI (NSTEMI). Data
were extracted from the NPR (PCI = procedure codes
FNG02 and FNG05, coronary artery bypass grafting
(CABG) = procedure codes FNA00, FNA10, FNA20,
FNA96, FNB00, FNB20, FNB96, FNC10, FNC20, FNC30,
FNC40, FNC50, FNC60, FNC96, FND10, FND20, FND96,
FNE00, FNE10, FNE20 and FNE96) and adjusted for gen-
der and age variations.
Figure 1. Locations and catchment areas of the 11 medical hospitals on the northern Norwegian mainland.





























The establishing of the NMIR was decided by the
Norwegian Parliament in April 2010 and initiated on 1
January 2012. Due to a low level of hospital participa-
tion during the initial years, we employed only the 2015
data. The following five quality indicators were
included:
● The rate of coverage, defined as the percentage of
all AMIs (according to the NPR) that was registered
in the NMIR database.
● The percentage of patients (< 80 years) diagnosed
with ST-elevated myocardial infarction (STEMI)
who underwent any reperfusion (thrombolytic
therapy, coronary angiography (CAG) with PCI).
● The percentage of STEMI patients (< 80 years)
treated with reperfusion in terms of thrombolytic
therapy within 30 minutes or CAG/PCI within
90 minutes after first medical contact.
● The percentage of non-STEMI (NSTEMI) patients
(< 80 years) who underwent CAG during therapy.
● The percentage of NSTEMI patients (< 80 years)
who underwent CAG within 72 hours after
hospitalisation.
Furthermore, we implemented from the NQCD the
30-day survival (first time AMI) figure for the 2012–2014
period. Each hospital’s value was calculated employing
the treatment chain method (www.fhi.no/www.helse
norge.no).
Data on air ambulance transportation was accessed
from the database at the NASN. All patients, trans-
ported by helicopter (rotor wing) or fixed wing aircraft,
diagnosed with AMI (ICD-10, I21/I22) were detected and
categorised according to urgency (ordered, normal,
urgent, acute), gender, time of initiation and the need
for an anesthesiologist during transport. This study per-
iod was from 1 January 2012 to 31 December 2014.
Statistical analysis and authorisation
The data from the NMIR was implemented from an
open source as aggregated and anonymous data [6].
Concerning the NPR data, the Centre for Clinical
Documentation and Evaluation (SKDE) at the NNRHA
trust had an approval from the NDI initially for the
2012–2014 period, and later for the 2013–2015 period.
They did also have an approval from the Northern
Regional Committee for Medical and Health Research
Ethics (REK) to publish anonymous data.
The NPR data included the whole cohort and descrip-
tive statistics were employed. Gender and age adjusted
rates of AMI, CAG and PCI were calculated and the false
discovery rate (FDR) measured. Furthermore, logistic
regression, multiple testing and the Chi-square test were
used. Significance was set to 5%. When analysing 30-day
survival, adjusted mortalities were estimated by logistic
regression. The analyses included age, sex, comorbidity
and number of prior hospitalisations. The method of Guo-
Romano with an indifference interval of 0.02 was used to
test whether a hospital was an outlier or not [19]. When
comparing sub-groups, institutions and counties with
regard to quality of care, we employed the Chi-square
test. The study was performed as a quality of care analysis.
Consequently, no ethical committee or Data Inspectorate
approval was necessary. Similarly, no approval from the




During the time 2012–2014, NPR registered 50,322
cases of AMI among 42,356 patients in Norway.
Details are given in Table 1. The northern region had
a 9% higher incidence rate of AMI, compared to Norway
in general. Within northern Norway, the northeastern
county (Finnmark) had the highest AMI rate per year
(4.84/1000 inhabitants) and the county hosting the PCI-
centre (Troms) the lowest one (2.8/1,000 inhabitants).
The national rate was 3.28/1000 inhabitants.
Looking at the incidence of AMI (according to hos-
pital catchment areas), we revealed UNN Tromsø had a
statistically significant lower incidence rate (2.7/1000
Table 1. Number of patients with acute myocardial infarction (AMI) according to Norwegian region and County in
northern Norway in 2012–2014. All rates were adjusted for differences in age and sex. Data from the Norwegian Patient
Registry.
Inhabitants AMI/1000 inhabitants/year AMI per year RR
Norway 5,107,711 3.28 16,774 1.00
Southeatern region 2,854,687 3.25 9,259 0.99
Western region 1,073,220 3.18 3,254 0.97
Central region 702,992 3.33 2,454 1.02
Northern Region 477,812 3.59 1,811 1.09
Nordland county 240,723 3.72 1,000 1.13
Troms county 161,974 2.8 454 0.85
Finnmark county 75,115 4.84 357 1.48





























inhabitants, p<0.0001) and a corresponding higher rate
was observed for Hammerfest hospital’s catchment area
(5.9/1000 inhabitants, p<0.0001). Furthermore, there
were significant variations in the rate of CAG between
hospital catchment areas. Details are given in Table 2.
Quality indicators
The 30-day survival following first time AMI revealed
inferior results in three hospitals and the statistically
significant best result was observed at the UNN
Tromsø (housing the PCI-centre) (p=0.0055). Details
are given in Table 2.
The 2015 quality of care indicators of the NMIR revealed
a rate of coverage ranging between 51% and 99%, a per-
centage of STEMI patients who underwent reperfusion
ranging between 42% and 100% and 0% and 38% of
reperfusions were performed within recommended time
limits. There was no statistical difference between
Northern Norway and Norway in general (p=0.22).
Because patients in the southern part of Northern Norway
are closer to the PCI centre of central Norway, located at St.
Olav’s hospital, Trondheim university hospital, 8.2% of
patients underwent PCI in other Norwegian health regions.
Furthermore, somepatients underwent PCIwhile theywere
on holiday or visiting other regions of Norway.
Depending on the primary hospital, the percentage
of NSTEMI patients who underwent CAG within
72 hours varied between 30% and 81% and in total
49% and 93% had a CAG performed. Although the
university hospital (UNN Tromsø), housing the PCI-cen-
tre, had the best quality of care results, we could not
document a correlation between quality of care and
distance to the PCI-centre. Each hospital’s distance in
kilometres to the PCI centre and their percentage of
AMI patients’ who had a PCI was plotted. A linear
regression analysis was performed (p=0.289). Further
details are illustrated in Table 3.
PCI, CABG and incidence of AMI
The PCI rate was significantly higher in one hospital
(Hammerfest) catchment area (p<0.0001). The correla-
tion between the incidence of AMI and revascularisa-
tion (PCI, coronary artery bypass grafting [CABG]) within
each hospital’s catchment area revealed that revascu-
larisation was significantly (p<0.01) more common in
the catchment area of UNN Tromsø. Details are shown
in Table 4. There was no correlation between 30-days
survival and rates of PCI (p=0.18), revascularisation
(p=0.97), AMI or revascularisation/AMI rate (p=0.30).
Furthermore, there was no correlation between 30-day
survival and rate of STEMI (p=0.64).
Fixed wing and rotor wing air ambulance services
A total of 2383 AMI patients were transported to
hospital using fixed wing and 338 patients by rotor
wing. This accounted for a total of 12.3% and 7.3% of
the fixed wing and rotor wing activity, respectively.
Whereas all rotor wing transportations had an anaes-
thesiologist on board, this was the case in 18% of
fixed wing transportations (41% of acute or urgency
operations). A nurse anaesthetist was a member of the
fixed wing crew. Urgent and acute operations
accounted for 46% of all AMI transports (99% of
rotor wing and 39% of fixed wing operations). Details
are shown in Table 5. When looking at the time of
initiation of the transport, we did not reveal any sig-
nificant pattern during the day for rotor wing missions.
However, when looking at fixed wing, a significant
drop was disclosed between 4 and 5 p.m., causing
an unequal service during the day. When exploring
this finding, we revealed the change of crew was
performed almost simultaneously. Consequently,
around 4 p.m. most planes were returning to their
base for the exchange of crewmembers.
Table 2. Rate of acute myocardial infarction (AMI), coronary angiography (CAG) and percutaneous coronary intervention (PCI) and
30-day survival in hospital catchment areas in Northern Norway 2013–2015.
Catchment area Inhabitants AMI rate (FDR) n CAG rate (FDR) n
30-day survival
% (FDR) PCI rate (FDR) N
Kirkenes 26,718 3.5 (0.9348) 94 7.2 (0.1507) 196 88.7 (0.2885) 2.8 (0.7554) 77
Hammerfest 48,806 5.9 (<0.0001) 263 11.0 (<0.0001) 517 89.7 (0.5000) 3.9 (<0.0001) 183
Tromsø 126,809 2.7 (<0.0001) 320 7.4 (0.0002) 890 92.1 (0.0055) 3.0 (0.1199) 363
Harstad 35,541 3.1 (0.2758) 118 5.6 (0.0922) 213 88.4 (0.2161) 2.4 (0.5679) 91
Narvik 27,134 3.1 (0.3768) 96 4.6 (0.0002) 132 86.7 (0.0099) 2.3 (0.4519) 67
Vesterålen 30,431 3.2 (0.4619) 109 6.4 (0.9746) 211 87.5 (0.0259) 2.7 (0.9127) 89
Lofoten 22,832 4.4 (0.0774) 109 6.4 (0.9976) 154 88.7 (0.3155) 2.4 (0.6880) 58
Bodø 83,642 3.7 (0.7270) 307 5.9 (0.0957) 490 88.9 (0.3566) 2.5 (0.7151) 212
Rana 33,693 3.1 (0.2883) 112 4.7 (<0.0001) 162 85.1 (0.0043) 2.1 (0.1746) 74
Mosjøen 16,316 4.0 (0.4453) 74 5.7 (0.2883) 104 — (—)* 2.5 (0.7554) 45
Sandnessjøen 28,367 3.3 (0.5376) 100 7.8 (0.0059) 237 89.9 (0.4705) 3.1 (0.4229) 94
Northern Norway 480,289 3.5 1701 6.8 3305 89.4 2.8 1351
* Figures not given due to <100 AMIs.






























We have revealed new knowledge concerning the inci-
dence of AMI in northern Norway.
Trends in the population burden of cardiovascular
disease (CVD) and associated lifestyle factors differ
between regions of the world [20–23]. Studies of the
temporal association of these patterns suggest that
changes in lifestyle factors precede the change in CVD
outcomes.
Effective cardiovascular treatment may also contri-
bute to a decline in CVD mortality [21].
For decades, the higher incidence of AMI in northern
Norway has been well known and especially the higher
incidence in Finnmark County [24]. However, the analy-
sis based on hospital catchment area revealed a large
difference within Finnmark County (between
Hammerfest and Kirkenes hospital). Obviously, this
must be followed up. Furthermore, the very low inci-
dence in Troms County was remarkable and should be
further elucidated. The city of Tromsø has, since 1994,
been the site of the population based “Tromsø study”
[25,26]. For more than 20 years (seven rounds), this
study has analysed the risk of coronary heart disease
within the population. This may have influenced the
risk of AMI. Furthermore, the city houses the regional
PCI centre and the UiT–The Arctic University of Norway.
The superior access to cardiovascular interventions and
the high number of academicians living in the city may
also have lowered the risk of AMI [27].
We revealed significant variations in 30-day survival
rate and access to CAG and revascularisation. It was
argued back in the 1990s that primary PCI offered the
best treatment results [28]. At that time, patients suc-
cessfully treated with thrombolytic therapy did not reg-
ularly undergo CAG [29]. However, in today’s studies on
pharmacological-invasive strategies, in example the
STREAM study, no significant difference between pre-















Norway** 88 94 38 58 75
Northern
Norway
92 94 20 57 75
Kirkenes 51 100 0 64 93
Hammerfest 99 42 0 30 54
Tromsø 98 99 21 81 89
Harstad 96 100 7 74 89
Narvik 73 100 0 64 77
Vesterålen 98 86 0 38 66
Lofoten 94 88 17 37 60
Bodø 84 93 35 57 75
Mo i Rana 93 96 17 39 49
Sandnessjøen 96 91 38 43 79
Mosjøen 92 100 0 38 57
* Coverage is the percentage of AMIs registered in the NMIR.
** The total figure of Norway includes also the figure of Northern Norway.
Table 4. Number of revascularisations, AMI, CAG and the rate








Kirkenes 81 100 100 201 1.0
Hammerfest 179 200 257 541 1.3
Tromsø 375 464 322 945 0.7
Harstad 91 115 127 219 1.1
Narvik 62 82 121 146 1.5
Vesterålen 84 104 119 210 1.1
Lofoten 66 81 127 167 1.6
Bodø 198 260 333 504 1.3
Mo i Rana 72 90 121 161 1.3
Sandnessjøen 83 108 100 234 0.9
Mosjøen 48 58 83 117 1.4
*Revascularisation = PCI and/or coronary artery bypass grafting (CABG).
**CAG was performed as a diagnostic procedure/control or as a combined
CAG-PCI procedure.
Table 5. An overview of the air ambulance activity (fixed wing
and rotor wing) in acute myocardial infarction in northern
Norway, according to the requisition forms filled out.
Fixed wing Rotor wing
Variable n % n % Total
Patients 19,298 80.6 4,637 19.4 23,935
AMI Total 2,383 87.6 338 12.4 2,721
Females 737 89.9 83 10.1 820
Males 1,603 85.9 264 14.1 1,867
Urgency* Ordered 221 99.5 1 0.5 222
Normal 1,241 99.8 2 0.2 1,243
Haste 323 86.1 52 13.9 375
Acute 598 67.9 283 32.1 881
* The urgency alternatives when requesting an air-ambulance: ordered (no
urgency given), normal, haste and acute. There were no definitions given
for the alternatives.





























hospital thrombolytic therapy and primary PCI has been
observed, in patients with limited symptom duration
[30]. Due to significant distances and only one PCI
centre, most patients cannot undergo primary PCI in
our region. Based on the STREAM study, it is under-
standable that we have achieved the same 30-day sur-
vival as observed in the other Norwegian health regions
performing mostly primary PCI. This is due to the fact
that we have put significant efforts into optimising
thrombolytic therapy and that we strive to provide
such treatment in the pre-hospital setting. Today our
emergency medical services perform the electrocardio-
grams (ECG) and communicate electronically with the
cardiologist/internist at the local hospital for diagnosis.
When a STEMI diagnosis is confirmed, thrombolytic
therapy is indicated and performed by ambulance
workers. In the future, the ambulance personnel may
be better educated and even perform the ECG diagno-
sis and, consequently, the procedure may be
speeded up.
The hospital catchment model documented signifi-
cant variations in 30-day survival in our region. Despite
these variations, survival rates in Norway have been
documented among the best in Europe and a positive
trend has been observed in most hospital catchment
areas during the last decade [9,31,32]. In this study, 30-
day survival was measured employing the “treatment
chain model”. However, local hospitals may be
bypassed in the treatment chain, generating differences
in case mix and making the treatment chain model
difficult to interpret.
In future studies, we recommend the treatment chain
model compared with a hospital catchment model.
Several international guidelines recommend that
NSTEMI patients should undergo CAG within 72 hours
after hospitalisation and some have advocated for a 24-
hour limit [33–35]. In 2015, 57% of NSTEMI patients in
our region weres treated within 72 hours. This was far
from the acceptable level of at least 70% [8]. The delay
may be due to in-hospital factors at the local hospital,
logistics and causes at the PCI-centre. All three alterna-
tives have to be followed up in the future. At present,
we are aware that the proportion is improving. During
the last quarter of 2016, 81% of NSTEMI patients under-
went CAG within 72 hours (personal communication,
Thor Trovik, UNN Tromsø). We strongly believe this is an
effect of the national quality of care register.
Today, patients with AMI experience prolonged sur-
vival and improved quality-of-life (QoL) [36,37]. The
NMIR had no QoL data and such studies were almost
absent in the medical literature. Consequently, we
could not document any differences in QoL between
hospital catchment areas. However, we are aware of
plans for implementing QoL measures in both the
NMIR and the Swedish register (SWEDEHEART) and
results could be available within a few years.
Finally, we observed significant differences in the access
of air ambulance resources during the day. A more asym-
metric exchange of crewmembers will be implemented.
Conclusion
Significant variations in the rate of AMI and unequal ser-
vice within the region was revealed. Initiatives to minimise
differences in quality of care must be taken. Quality of care
indicators are important instruments in the struggle for
improvements in the healthcare of AMI patients. In the
future, we have to further optimise the treatment chain
and we believe QoL figures will be important for the fine-
tuning of treatment strategies in the near future.
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